GeneBioTech Co. Ltd (086060) — Free Cash Flow Generation Index
GeneBioTech Co. Ltd (086060) has a Free Cash Flow Generation Index of 0.95x as of September 2025. Free cash flow of ₩3.68 Billion represents 1% of operating cash flow (₩3.87 Billion). Read GeneBioTech Co. Ltd (086060) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
GeneBioTech Co. Ltd Free Cash Flow Generation Index (2009–2023)
Historical FCF Generation Index trend for GeneBioTech Co. Ltd across 11 annual periods. Explore GeneBioTech Co. Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for GeneBioTech Co. Ltd (2009–2023)
Year-by-year Free Cash Flow Generation Index for GeneBioTech Co. Ltd. For the full company profile including market capitalisation, see GeneBioTech Co. Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.90x | ₩6.60 Billion | ₩7.37 Billion | ₩766.93 Million | ▲ +217.8% |
| 2020 | -0.76x | ₩-1.90 Billion | ₩2.49 Billion | ₩4.39 Billion | ▼ -169.5% |
| 2018 | 1.09x | ₩6.51 Billion | ₩5.96 Billion | ₩558.47 Million | ▼ -44.7% |
| 2017 | 1.98x | ₩2.24 Billion | ₩1.13 Billion | ₩1.11 Billion | ▲ +59.0% |
| 2016 | 1.24x | ₩6.61 Billion | ₩5.31 Billion | ₩1.30 Billion | ▼ -8.3% |
| 2015 | 1.36x | ₩3.53 Billion | ₩2.61 Billion | ₩927.06 Million | ▲ +9.6% |
| 2014 | 1.24x | ₩2.67 Billion | ₩2.15 Billion | ₩510.55 Million | ▼ -0.6% |
| 2013 | 1.24x | ₩2.96 Billion | ₩2.38 Billion | ₩582.01 Million | ▼ -37.6% |
| 2011 | 1.99x | ₩5.04 Billion | ₩2.53 Billion | ₩2.51 Billion | ▲ +25.0% |
| 2010 | 1.60x | ₩1.86 Billion | ₩1.17 Billion | ₩693.45 Million | ▲ +46.9% |
| 2009 | 1.09x | ₩2.91 Billion | ₩2.68 Billion | ₩229.99 Million | — |